SEC Form 4 research

DiaMedica Therapeutics Inc. insider transactions

Recent insider disclosures

Officers and directors in the directory

• Semba Charles Pauling — 1 qualifying
• Burroughs Amy L. — 12 qualifying
• Giuffre Randall Michael — 11 qualifying
• Pilnik Richard D. — 9 qualifying
• Kellen Scott — 11 qualifying
• Parsons James T. — 3 qualifying
• Wambeke David J. — 5 qualifying
• Pauls Dietrich John — 5 qualifying
• ALCORN HARRY W JR — 7 qualifying
• Verdoorn Todd A. — 1 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.